Further, while the mCRP domain associated with fibronectin and collagen binding was essential for its ability to induce IL-6 secretion from peritoneal immune cells (e.g., macrophages) [18], how this may reflect the outcome of its interactions with these glycoproteins in a tumor in situ has yet to be described. The gene discussed is FN1; the disease is neoplasm.